The risk of recurrent VTE and major bleeding in a commercially‐insured population of cancer patients treated with anticoagulation. Issue 2 (18th December 2018) - Khorana, Alok A.; McCrae, Keith; Milentijevic, Dejan; McCormick, Nora; Laliberté, François; Crivera, Concetta; Lefebvre, Patrick; Lejeune, Dominique; Rozjabek, Heather; Schein, Jeff; Streiff, Michael B.